VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 178 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $235,046 | -39.4% | 31,806 | -18.9% | 0.01% | -41.2% |
| Q3 2022 | $388,000 | -9.8% | 39,225 | -0.6% | 0.02% | -5.6% |
| Q2 2022 | $430,000 | -1.1% | 39,454 | +2.6% | 0.02% | 0.0% |
| Q1 2022 | $435,000 | -33.4% | 38,438 | -7.7% | 0.02% | -21.7% |
| Q4 2021 | $653,000 | -31.0% | 41,638 | -24.6% | 0.02% | -32.4% |
| Q3 2021 | $946,000 | -23.0% | 55,206 | -3.3% | 0.03% | -17.1% |
| Q2 2021 | $1,228,000 | +47.6% | 57,086 | +3.0% | 0.04% | +57.7% |
| Q1 2021 | $832,000 | +11.4% | 55,408 | -2.6% | 0.03% | +4.0% |
| Q4 2020 | $747,000 | – | 56,875 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Profit Investment Management, LLC | 326,997 | $1,412,627 | 1.00% |
| Stonepine Capital Management, LLC | 477,903 | $2,064,541 | 0.69% |
| Krensavage Asset Management, LLC | 360,429 | $1,557 | 0.57% |
| Nantahala Capital Management | 1,000,000 | $4,320,000 | 0.37% |
| Monaco Asset Management SAM | 135,000 | $583,200 | 0.17% |
| CTC Alternative Strategies, Ltd. | 18,400 | $79,488 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 406,019 | $1,754 | 0.15% |
| Sio Capital Management, LLC | 97,616 | $421,701 | 0.13% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 156,000 | $673,920 | 0.13% |
| Virtus ETF Advisers LLC | 48,530 | $209,650 | 0.13% |